Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Lu

Showing results (951-960 of 1,101) with videos related to

Pageof 111
Sort By:
Purinergic Signalling|March 27, 2017
Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injuryMaithili Sashindranath, Karen M Dwyer, Shala Dezfouli, et al.
Journal of Hematology & Oncology|September 25, 2016
Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapyGregory S Alexander, Joshua D Palmer, Madalina Tuluc, et al.
Oxidative Medicine and Cellular Longevity|December 7, 2017
Nrf2, a Potential Therapeutic Target against Oxidative Stress in Corneal DiseasesXiu-Fen Liu, Dan-Dan Zhou, Tian Xie, et al.
Molecular Cancer Therapeutics|February 28, 2013
ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALKYunguang Sun, Kamila A Nowak, Nicholas G Zaorsky, et al.
International Journal of Clinical Practice|January 9, 2023
Differences in Clinical and Imaging Features between Asymptomatic and Symptomatic COVID-19 PatientsXi Ma, Zhi-Yan Lu, Yan-Juan Qu, et al.
The Journal of Biological Chemistry|May 28, 2016
Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP SignalingHui Wang, Bo Lu, Johnny Castillo, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 18, 2004
Surgical treatment of 1360 cases of Budd-Chiari syndrome: 20-year experiencePei-Qin Xu, Xiu-Xian Ma, Xue-Xiang Ye, et al.
Annals of Neurology|March 14, 2014
Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injuryNai-Kui Liu, Ling-Xiao Deng, Yi Ping Zhang, et al.
Addictive Behaviors|August 5, 2025
Longitudinal analysis of e-cigarette and cannabis dual use in an Ohio sample of adolescents and young adultsVitoria B Spinola, Jill M Singer, Elizabeth G Klein, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 25, 2024
[Cloning and functional analysis of flavanone synthase Ⅱ from Dendrobium huoshanense]Hai-Bo Lu, Xiao Huang, Zhi-Yu Zheng, et al.
Pageof 111

Showing results (951-960 of 1,101) with videos related to

Sort By:
Pageof 111
Purinergic Signalling|March 27, 2017
Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injuryMaithili Sashindranath, Karen M Dwyer, Shala Dezfouli, et al.
Journal of Hematology & Oncology|September 25, 2016
Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapyGregory S Alexander, Joshua D Palmer, Madalina Tuluc, et al.
Oxidative Medicine and Cellular Longevity|December 7, 2017
Nrf2, a Potential Therapeutic Target against Oxidative Stress in Corneal DiseasesXiu-Fen Liu, Dan-Dan Zhou, Tian Xie, et al.
Molecular Cancer Therapeutics|February 28, 2013
ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALKYunguang Sun, Kamila A Nowak, Nicholas G Zaorsky, et al.
International Journal of Clinical Practice|January 9, 2023
Differences in Clinical and Imaging Features between Asymptomatic and Symptomatic COVID-19 PatientsXi Ma, Zhi-Yan Lu, Yan-Juan Qu, et al.
The Journal of Biological Chemistry|May 28, 2016
Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP SignalingHui Wang, Bo Lu, Johnny Castillo, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 18, 2004
Surgical treatment of 1360 cases of Budd-Chiari syndrome: 20-year experiencePei-Qin Xu, Xiu-Xian Ma, Xue-Xiang Ye, et al.
Annals of Neurology|March 14, 2014
Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injuryNai-Kui Liu, Ling-Xiao Deng, Yi Ping Zhang, et al.
Addictive Behaviors|August 5, 2025
Longitudinal analysis of e-cigarette and cannabis dual use in an Ohio sample of adolescents and young adultsVitoria B Spinola, Jill M Singer, Elizabeth G Klein, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 25, 2024
[Cloning and functional analysis of flavanone synthase Ⅱ from Dendrobium huoshanense]Hai-Bo Lu, Xiao Huang, Zhi-Yu Zheng, et al.
Pageof 111